• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：黄等人。四价流感亚单位疫苗在6至35个月健康儿童中的安全性和免疫原性：一项随机、盲法和阳性对照的III期临床试验。2025年，467。

Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. 2025, 467.

作者信息

Huang Lili, Li Guangfu, Zhang Yuhui, Zhao Xue, Wang Kai, Jia Chunyu, Zhang Wei, Tan Jiebing, Chen Xiaofen, Li Qin, Jiang Hongyan, An Rui, Leng Wenna, Yang Yongli, An Youcai, Wang Yanxia, Zhang Yaodong

机构信息

Henan Provincial Centre for Disease Control and Prevention, Zhengzhou 450016, China.

Ab&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.

出版信息

Vaccines (Basel). 2025 Aug 1;13(8):826. doi: 10.3390/vaccines13080826.

DOI:10.3390/vaccines13080826
PMID:40872972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389928/
Abstract

The authors would like to make the following corrections to this published paper [...].

摘要

作者希望对已发表的该论文做出如下更正

[...]

相似文献

1
Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial. 2025, 467.更正：黄等人。四价流感亚单位疫苗在6至35个月健康儿童中的安全性和免疫原性：一项随机、盲法和阳性对照的III期临床试验。2025年，467。
Vaccines (Basel). 2025 Aug 1;13(8):826. doi: 10.3390/vaccines13080826.
2
The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial.6至35月龄健康儿童四价流感亚单位疫苗的安全性和免疫原性：一项随机、盲法和阳性对照的III期临床试验。
Vaccines (Basel). 2025 Apr 26;13(5):467. doi: 10.3390/vaccines13050467.
3
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older.一项针对50岁及以上成年人的MF59佐剂四价亚单位细胞衍生流感疫苗（aQIVc）的随机2期免疫原性和安全性研究。
Vaccine. 2025 Apr 2;51:126791. doi: 10.1016/j.vaccine.2025.126791. Epub 2025 Feb 12.
4
Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9-59 years: A randomized, double-blind, controlled, phase IV clinical trial.四价裂解病毒流感疫苗在 9-59 岁健康人群中的批间一致性、免疫原性和安全性：一项随机、双盲、对照、四期临床试验。
Vaccine. 2024 Aug 30;42(21):126182. doi: 10.1016/j.vaccine.2024.126182. Epub 2024 Aug 6.
5
Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.伊朗（FluGuard）四价重组流感疫苗在 18-60 岁志愿者中的免疫原性和安全性：一项双盲、非劣效、随机对照试验。
Vaccine. 2024 Apr 2;42(9):2254-2259. doi: 10.1016/j.vaccine.2024.02.073. Epub 2024 Feb 29.
6
Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial.≥50岁成人流感与新冠多组分疫苗的免疫原性和安全性：一项随机临床试验
JAMA. 2025 May 7. doi: 10.1001/jama.2025.5646.
7
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial.四价脑膜炎球菌结合疫苗（MenACYW-TT）与常规儿科疫苗联合接种的免疫原性和安全性：一项欧洲随机对照试验。
Infect Dis Ther. 2025 Jul 15. doi: 10.1007/s40121-025-01190-7.
8
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age.一项针对18至45岁健康成年人开展的I期研究，旨在探究两种四价季节性流感疫苗（Fluzone®或Flublok®）添加或不添加两种佐剂（AF03或Advax-CpG55.2）之一时的安全性、反应原性和免疫原性。
Vaccine. 2025 Apr 30;54:126991. doi: 10.1016/j.vaccine.2025.126991. Epub 2025 Mar 18.
9
Vaccines for preventing influenza in healthy children.用于预防健康儿童流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.
10
Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis.6 至 35 月龄儿童接种四价灭活流感疫苗的免疫原性和安全性：系统评价和荟萃分析。
Hum Vaccin Immunother. 2023 Aug;19(2):2256510. doi: 10.1080/21645515.2023.2256510. Epub 2023 Oct 4.

本文引用的文献

1
The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial.6至35月龄健康儿童四价流感亚单位疫苗的安全性和免疫原性：一项随机、盲法和阳性对照的III期临床试验。
Vaccines (Basel). 2025 Apr 26;13(5):467. doi: 10.3390/vaccines13050467.